Advertisement

< Back to Article

APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts

Table 5

Lifetime (to age 80–85 y) cumulative incidence of dementia by baseline age and APOE-e4 dose.

Table 5

doi: https://doi.org/10.1371/journal.pmed.1002254.t005